| Apr 14, 2015
| 6:35 AM
U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act.
Spending rose 13 percent, the...
| Apr 14, 2015
| 1:02 AM
A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.
Attorney Lisa Blatt told...
| Apr 9, 2015
| 3:10 AM
In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion.
Shares of both companies climbed to all-time highs on the news. If they combine, Mylan...
| Apr 8, 2015
| 11:35 AM
Generic drugmaker Mylan has made a bid to buy the Dublin-based drugmaker Perrigo Co. in a deal valued at about $29 billion.
Mylan offered $205 per share in cash and stock. The offer was contained in a letter delivered to Perrigo CEO Joseph Papa on Monday...
| Apr 7, 2015
| 1:49 PM
Drug and medical device maker Hospira said Tuesday that it received a warning letter from the Food and Drug Administration following an inspection at a company factory in Italy.
The company has received five warnings from the FDA in less than two years....
| Apr 7, 2015
| 1:22 PM
The Food and Drug Administration has warned Hospira that corrective actions the drugmaker made at an Italy facility weren't sufficient, the company disclosed Tuesday in a regulatory filing.
The FDA in a March 31 letter said Hospira lacked written...
| Mar 18, 2015
| 3:28 PM
The Food and Drug Administration on Tuesday approved Cholbam, developed by Baltimore biotechnology company Asklepion Pharmaceuticals, for treatment of a rare disease that prevents people from making key digestive acids.
The approval means Retrophin, a...
| Mar 17, 2015
| 10:39 AM
The $70-billion purchase of Botox maker Allergan Inc. of Irvine by Irish company Actavis has closed, Actavis confirmed Tuesday.
Allergan’s longtime leader, David E.I. Pyott, will not have a position in the new company, which will be called...
| Apr 2, 2015
| 3:46 PM
British drug maker GlaxoSmithKline is establishing a vaccine research center in Rockville that it expects will bring 600 jobs to the state.
The site will join others in Belgium and Italy as one of the company's three hubs for vaccine research and...
| Mar 14, 2015
The story of MedImmune, the Maryland startup that British pharmaceutical giant AstraZeneca bought for $15.6 billion in 2007, is an example for entrepreneurs striving for their own blockbuster deals. But MedImmune leaders say they want to go beyond leading...
| Apr 1, 2015
| 10:10 AM
Some 35 years ago my grandfather died a painful death as prostate cancer ravaged his body. His passing did not have to be so excruciating given that hospital staff could have eased his suffering with pain medication. But when my mother asked about the...